Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Pulmonx Corp (LUNG)

Pulmonx Q3 revenue rises 6% to $22.8 million; net loss narrows to $8.4 million

Positive Impact 3 of 5 earnings Written later

Pulmonx reported third-quarter 2026 revenue of $22.8 million, up 6% from a year earlier, and a net loss of $8.4 million, or $0.19 per share, compared with a $14.0 million loss, or $0.34 per share, a year earlier. The company kept its full-year 2026 revenue outlook at $90 million to $92 million, and it expects cash, cash equivalents, and marketable securities to decline by about $22 million for the year.

Key points

  • Q3 2026 revenue was $22.8 million, up from $21.5 million; U.S. revenue rose 7% and international revenue rose 5%, with international growth tempered by no sales to its China distributor
  • Net loss was $8.4 million, or $0.19 per share, versus $14.0 million, or $0.34 per share, in Q3 2025; operating expenses fell 18% to $24.9 million
  • Full-year 2026 revenue guidance of $90 million to $92 million was unchanged; the company expects gross margin of about 77% and operating expenses of $108 million to $109 million
  • Nine-month revenue was $66.2 million, down 2.5% from $67.9 million a year earlier

The filing

CompanyPulmonx Corp (LUNG)
Form8-K, current report
Filed with the SECOct 27, 2026, 4:07 PM ET
Accession number0001127537-26-000042

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:36 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 27, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.